The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Geographic and ethnic heterogeneity in the BRCA1/2 pre-screening population for the randomized phase III POLO study of olaparib maintenance in metastatic pancreatic cancer (mPC).
 
Talia Golan
Honoraria - Bristol-Myers Squibb; MSD; Rafael Pharmaceuticals
Consulting or Advisory Role - Abbvie; AstraZeneca
 
Hedy L. Kindler
Consulting or Advisory Role - Aduro Biotech; AstraZeneca; Bayer; Boehringer Ingelheim; Bristol-Myers Squibb; Celgene; ERYTECH Pharma; Five Prime Therapeutics; GlaxoSmithKline; ipsen; MedImmune; Merck; Paradox Therapeutics
Research Funding - Aduro Biotech; AstraZeneca; Bayer; Bristol-Myers Squibb; Deciphera; GlaxoSmithKline; Lilly; MedImmune; Merck; Polaris; Verastem
 
Joon Oh Park
Honoraria - Celgene
Consulting or Advisory Role - Celgene
Speakers' Bureau - Celgene; Celgene; Celgene
Research Funding - AstraZeneca; Celgene
 
Michele Reni
Honoraria - Baxalta/Shire
Consulting or Advisory Role - Baxalta/Shire; Celgene; Novartis; Novocure; Pfizer
Research Funding - Celgene
Travel, Accommodations, Expenses - Celgene
 
Teresa Macarulla Mercade
No Relationships to Disclose
 
Pascal Hammel
Honoraria - Celgene
Consulting or Advisory Role - Celgene; Shire
Speakers' Bureau - Celgene
Travel, Accommodations, Expenses - Ipsen; Merck Serono
 
Eric Van Cutsem
Consulting or Advisory Role - Bayer; Lilly; Roche; SERVIER
Research Funding - amgen (Inst); Bayer (Inst); Boehringer Ingelheim (Inst); Celgene (Inst); Ipsen (Inst); Lilly (Inst); Merck (Inst); Merck KGaA (Inst); Novartis (Inst); Roche (Inst); Sanofi (Inst); SERVIER (Inst)
 
Dirk Arnold
Honoraria - Bayer/Vital; Roche Pharma AG; Sanofi/Regeneron; Servier/Pfizer
Consulting or Advisory Role - Lilly/ImClone; Merck Serono; Roche/Genentech; Servier; Sirtex Medical; TERUMO
Travel, Accommodations, Expenses - Bayer Health; Roche/Genentech; Sanofi
 
Daniel Hochhauser
Stock and Other Ownership Interests - Novartis; Roche
Research Funding - Merck Serono
Travel, Accommodations, Expenses - Celgene
 
Gershon Y. Locker
Employment - AstraZeneca
Stock and Other Ownership Interests - AstraZeneca
 
Michael J. Hall
Patents, Royalties, Other Intellectual Property - I share a patent with several Fox Chase investigators for a novel method to investigate hereditary CRC genes (Inst)
Travel, Accommodations, Expenses - Foundation Medicine
Other Relationship - Caris Life Sciences; Foundation Medicine; Invitae; Myriad Genetics